Challenges Facing Ayurvedic Pharma Franchise

About This Presentation
Title:

Challenges Facing Ayurvedic Pharma Franchise

Description:

Once a respected and widely followed medical school, Ayurveda no longer enjoys that position. Like most traditional medicines around the world, it has dedicated followers, but lacks a more organised impact on the market... – PowerPoint PPT presentation

Number of Views:4

less

Transcript and Presenter's Notes

Title: Challenges Facing Ayurvedic Pharma Franchise


1
Welcome To Saflon Life Sciences
2
Challenges Facing Ayurvedic Pharma Franchise
Once a respected and widely followed medical
school, Ayurveda no longer enjoys that position.
Like most traditional medicines around the world,
it has dedicated followers, but lacks a more
organised impact on the market. It is often
categorised as an alternative medicine,
especially in the international market. However,
it has made a more focused comeback in the recent
years. Bigger FMCG corporations have made
considerable inroads into the market, especially
in cosmetic remedies. Recent government support
has further encouraged the industry. The forecast
for the Ayurvedic industry is encouraging with
experts predicting a double figure growth in the
next few years. However, challenges facing
Ayurvedic pharma franchise still remain.
3
Lack of validation of Products
If you were to research on an allopathic drug you
will find reams of data. This is usually years of
research conducted by various labs at different
locations and different points of time. This is
usually backed by validation by multiple experts,
including doctors and physicians. In contrast
Ayurvedic medicine has a fraction of such
validation. There are almost no validations by
reputed labs and doctors who are not directly
involved with the industry. This makes it
difficult for Ayurvedic companies to create a
valid, reliable and reputable image in new
markets where it must make a name from scratch.
4
Lack of quality control procedures
There is still a poor quality control regimen for
Ayurvedic products. In fact, rules and
regulations that govern Ayurvedic products can
seem very lax when compared with allopathic
medicine. Allopathic drugs have to go through
stringent tests and years of observation on side
effects. All this is also carefully documented
and validated by independent labs. Unfortunately,
such an independent infrastructure is still
poorly established when it comes to Ayurvedic
medicine validation. This becomes a problem when
dealing with markets with strict drug
regulations. As a result, Ayurvedic pharma
franchise products are often rejected because of
lack of proper documentation.
5
Lack of process validation
As explained above, allopathic medicines have to
be under strict regulation. This includes the
processes to produce the drugs. These are clearly
defined and laid down. Any departure from the
process can lead to withdrawal of license.
However, the process in Ayurveda is often
shrouded in mystery. As with many traditional
medicines, there is no way of guaranteeing one
process as more authentic than another. This
makes the laying down of a validated process all
the more difficult.
6
For customer relationship
The nature of customer relationship is changing
rapidly. The modern buyer of a pharma franchise
in India is connected, informed and quick to air
his/her thought. Customer relationships today are
managed on multiple platforms - from social
media, web search to customer profiling. This
requires a mammoth effort on most organisations,
from managing regular mails to keeping their
customer data updated.
7
Batch to batch variation in product
Ayurvedic medicine manufacturing is not always an
exact science. Although considerable progress has
been made in regularising the production of
Ayurvedic products and processes, there can still
be variations in the products of a certain
company. Unlike allopathic medicines we are not
dealing with precise formulas. Hence, the product
of one company can differ from another even when
it is the same medicine. This creates problems
for Ayurvedic pharma franchise when dealing with
more regularised markets where such uniformity is
essential.
8
Presence of toxicity in certain samples
One of the biggest hurdles faced by Ayurvedic
medicines is the detection of toxic material like
arsenal and lead in some of the samples. Ayurveda
does use certain metals, but the traditional
remedies did not have any high levels of
toxicity. The presence could have been due to
contaminated samples or contaminated raw
material. Unfortunately, the detection of such
ingredients has effected the reputation of
Ayurveda in developed markets where it has done
irreparable damage to its reputation.
9
Lack of consolidation
Unlike well-organised medical bodies on State and
national level, Ayurvedic doctors lack a
consolidated body.Ayurveda is still largely
practised by lone physicians. Most practitioners
are found in rural areas. Even the industry lack
proper consultation with many players belonging
to the small and medium sector. This means that
they are not able to act in a unified manner or
represent their concerns in front of the
concerned ministries. This has also led to the
fractured nature of the industry itself with
inadequate rules and regulations.
10
Effect of pollution
Ayurvedic medicines are not chemicals whose
quality only depends on the right proportions. In
Ayurveda we use naturally available herbs and
other trace elements. Unfortunately, it also
makes the overall product susceptible to effects
of pollution. Despite using the right herbs, the
quality of the medicine can be sub-par because
the herbs themselves have been contaminated
through pollutants in the soil. Conclusion With
a focused push from the government Ayurveda can
finally have its day, becoming as popular as yoga
in the international scene. However, to achieve
this success it is important that we meet these
unique challenges.
11
Contact Us
Saflon Lifesciences pvt. ltd. Shop No.8, 1st
Floor, J.P. Complex,Near Naroda Old Police
Station,Naroda, Ahmedabad - 382330Gujarat,
IndiaPhone 91 99984 41626   91 999844 1771
Write a Comment
User Comments (0)